Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents

E-ISSN： 2212-3970|1|3|327-346

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.1, Iss.3, 2006-11, pp. : 327-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy

Current Cancer Therapy Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 117-126

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Therapies that Utilize Cell Penetrating Peptides

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-01 ,pp. : 99-108

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Surface Nucleolin as a Target for Anti-Cancer Therapies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 2, 2014-05 ,pp. : 137-152

Bentham Science Publishers

Access to resources Recommend Favorite

Prescribing anti-cancer drugs in elderly cancer patients

By Monfardini S.

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2341-2346

Elsevier

Access to resources Recommend Favorite

Congrès Targeted Anticancer Therapies — TAT 2013

By Arrondeau J. Helissey C. Tlemsani C. Boussion H. Cohen R. Riet F. Vignot S.

Oncologie, Vol. 15, Iss. 7-8, 2013-07 ,pp. : 415-423

Springer Publishing Company

Access to resources Recommend Favorite